Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Here’s What Happened

Hypermarcas (OTCMKTS:HYPMY) shares gapped up prior to trading on Wednesday . The stock had previously closed at $4.65, but opened at $4.80. Hypermarcas shares last traded at $4.80, with a volume of 1,100 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, Hypermarcas currently has an average rating of “Buy”.

Hypermarcas Stock Performance

The firm has a fifty day moving average of $4.25 and a 200-day moving average of $4.30. The company has a quick ratio of 1.26, a current ratio of 1.86 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $3.35 billion, a price-to-earnings ratio of 9.52 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last posted its earnings results on Thursday, August 6th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.01. Hypermarcas had a return on equity of 12.68% and a net margin of 19.77%. As a group, sell-side analysts anticipate that Hypermarcas will post 0.53 EPS for the current year.

Hypermarcas Company Profile

Hypermarcas SA was a Brazilian consumer health and pharmaceutical company that developed, manufactured and marketed branded products for healthcare, personal care and consumer markets. Its portfolio historically included over-the-counter medicines, prescription products, vitamins, toiletries, cosmetics and other household or personal-care brands.

The company expanded through acquisitions and operated primarily in Brazil, building a broad portfolio of locally recognized brands. In the mid-2010s, Hypermarcas began divesting its non-pharmaceutical businesses to concentrate on healthcare and medicines.